| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.32 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |